Cost-effectiveness of Dabigatran
A paper published by James Freeman* and colleagues in 2009, looked at the cost-effectiveness of Dabigatran compared with Warfarin for stroke prevention in atrial fibrillation.
Using the ten criteria set out above by Drummond think about how the authors have conducted their analysis. Select two of the criteria and briefly describe two key aspects from the Freeman’s paper and place on the discussion board.
Freeman et al., (2009) Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.